Received Feb 17, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| PNC21 | PNEUMO (CAPVAXIVE) | MERCK & CO. INC. | UNK | Z007870 | — |
No adverse effects were reported; Medical Assistant called to report the inadvertent administration of CAPVAXIVE that SANOFI stated was non-viable due to extended shipping duration; This spontaneous report was received from a medical assistant and refers to a 58-year-old female patient. The patient's medical history, concurrent conditions and concomitant therapies were not reported. On 26-Jan-2026, the Pneumococcal 21-valent Conjugate Vaccine (CAPVAXIVE) was shipped on and was not received until 06-Feb-2026. On 10-Feb-2026, the patient was inadvertently vaccinated with a dose of Pneumococcal 21-valent Conjugate Vaccine (CAPVAXIVE) injection 168 mcg/ml (lot #Z007870 with valid expiration date reported as 23-Oct-2026) 0.5 mL (route of administration and vaccination site were not reported) administered for prophylaxis. The vaccine was non-viable due to extended shipping duration. The vaccine was placed in the refrigerator with a "do not use" tag attached to it, while waiting for a return shipping label to be sent, and a nurse missed the tag and accidentally administered it to a patient (product storage error). No adverse effects were reported (no adverse event). No additional adverse event (AE) and no product quality complaint (PQC) was noted.